Loxo Oncology, Inc. 4
4 · Loxo Oncology, Inc. · Filed Jul 30, 2015
Insider Transaction Report
Form 4
Naider Avi Z.
Director
Transactions
- Award
Director Stock Option (right to buy)
2015-07-28+7,812→ 7,812 totalExercise: $20.91Exp: 2025-07-27→ Common Stock (7,812 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.